News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
159,170 Results
Type
Article (10937)
Company Profile (9)
Press Release (148224)
Multimedia
Podcasts (17)
Webinars (1)
Section
Business (53139)
Career Advice (620)
Deals (7564)
Drug Delivery (34)
Drug Development (34997)
Employer Resources (38)
FDA (4573)
Job Trends (3929)
News (96903)
Policy (7389)
Tag
Academia (588)
Accelerated approval (2)
Adcomms (12)
Allergies (37)
Alliances (7614)
ALS (47)
Alzheimer's disease (431)
Antibody-drug conjugate (ADC) (56)
Approvals (4580)
Artificial intelligence (49)
Autoimmune disease (11)
Automation (1)
Bankruptcy (57)
Best Places to Work (3427)
BIOSECURE Act (5)
Biosimilars (35)
Biotechnology (5)
Bladder cancer (41)
Brain cancer (12)
Breast cancer (117)
Cancer (932)
Cardiovascular disease (81)
Career advice (516)
Career pathing (11)
CAR-T (67)
Cell therapy (149)
Cervical cancer (11)
Clinical research (30348)
Collaboration (143)
Company closure (1)
Compensation (64)
Complete response letters (8)
COVID-19 (1034)
CRISPR (13)
C-suite (30)
Cystic fibrosis (31)
Data (954)
Denatured (4)
Depression (22)
Diabetes (96)
Diagnostics (1308)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (29)
Drug pricing (36)
Drug shortages (6)
Duchenne muscular dystrophy (37)
Earnings (39309)
Editorial (14)
Employer branding (7)
Employer resources (34)
Events (16907)
Executive appointments (72)
FDA (5092)
Frontotemporal dementia (2)
Funding (163)
Gene editing (31)
Generative AI (6)
Gene therapy (113)
GLP-1 (286)
Government (1134)
Grass and pollen (2)
Guidances (80)
Healthcare (4128)
Huntington's disease (10)
IgA nephropathy (14)
Immunology and inflammation (50)
Indications (17)
Infectious disease (1087)
Inflammatory bowel disease (44)
Inflation Reduction Act (6)
Influenza (19)
Intellectual property (30)
Interviews (117)
IPO (4470)
IRA (21)
Job creations (662)
Job search strategy (412)
Kidney cancer (7)
Labor market (14)
Layoffs (193)
Leadership (4)
Legal (873)
Liver cancer (41)
Lung cancer (170)
Lymphoma (74)
Management (9)
Manufacturing (78)
MASH (35)
Medical device (2943)
Medtech (2945)
Mergers & acquisitions (3232)
Metabolic disorders (281)
Multiple sclerosis (53)
NASH (12)
Neurodegenerative disease (38)
Neuropsychiatric disorders (16)
Neuroscience (685)
NextGen: Class of 2025 (1194)
Non-profit (799)
Now hiring (3)
Obesity (151)
Opinion (72)
Ovarian cancer (33)
Pain (31)
Pancreatic cancer (41)
Parkinson's disease (61)
Partnered (3)
Patents (54)
Patient recruitment (47)
Peanut (21)
People (5428)
Pharmaceutical (7)
Pharmacy benefit managers (4)
Phase I (7934)
Phase II (13297)
Phase III (12138)
Pipeline (739)
Policy (47)
Postmarket research (804)
Preclinical (2118)
Press Release (7)
Prostate cancer (52)
Psychedelics (15)
Radiopharmaceuticals (69)
Rare diseases (132)
Real estate (895)
Recruiting (21)
Regulatory (6160)
Reports (14)
Research institute (477)
Resumes & cover letters (120)
Rett syndrome (2)
RNA editing (1)
RSV (24)
Schizophrenia (41)
Series A (29)
Series B (17)
Service/supplier (1)
Sickle cell disease (21)
Special edition (5)
Spinal muscular atrophy (71)
Sponsored (9)
Startups (623)
Stomach cancer (8)
Supply chain (14)
Tariffs (6)
The Weekly (12)
Vaccines (294)
Venture capitalists (16)
Weight loss (107)
Women's health (5)
Worklife (6)
Date
Today (17)
Last 7 days (319)
Last 30 days (861)
Last 365 days (9558)
2025 (3325)
2024 (10254)
2023 (11504)
2022 (14766)
2021 (14952)
2020 (13445)
2019 (10504)
2018 (7801)
2017 (8684)
2016 (7452)
2015 (8899)
2014 (6208)
2013 (4650)
2012 (4873)
2011 (5072)
2010 (4621)
Location
Africa (188)
Alabama (13)
Alaska (1)
Arizona (35)
Arkansas (2)
Asia (10629)
Australia (1758)
California (1894)
Canada (566)
China (177)
Colorado (71)
Connecticut (72)
Delaware (64)
Europe (23298)
Florida (254)
Georgia (78)
Idaho (10)
Illinois (118)
India (4)
Indiana (109)
Japan (70)
Kansas (29)
Kentucky (5)
Louisiana (2)
Maine (24)
Maryland (210)
Massachusetts (1293)
Michigan (53)
Minnesota (84)
Missouri (22)
Montana (7)
Nebraska (2)
Nevada (16)
New Hampshire (16)
New Jersey (697)
New Mexico (3)
New York (558)
North Carolina (201)
Northern California (897)
Ohio (33)
Oregon (3)
Pennsylvania (391)
Puerto Rico (8)
Rhode Island (4)
South America (280)
South Carolina (1)
Southern California (696)
Tennessee (31)
Texas (221)
United States (6676)
Utah (43)
Virginia (26)
Washington D.C. (10)
Washington State (162)
Wisconsin (11)
159,170 Results for "second sight".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sight Sciences Appoints Gary Burbach to its Board of Directors
April 23, 2025
·
7 min read
Press Releases
Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance
May 9, 2025
·
16 min read
Press Releases
Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025
April 25, 2025
·
2 min read
Press Releases
Bionic Sight’s BS01 Gene Therapy Receives RMAT Designation from the FDA
February 18, 2025
·
3 min read
Collaboration
AstraZeneca Sets Sights and $1.35B on Subcutaneous Cancer Drugs With Alteogen Alliance
Monday was a busy day for AstraZeneca, which also paid up to $1 billion to acquire Belgian biotech EsoBiotec and its cell therapy pipeline and technology.
March 18, 2025
·
2 min read
·
Tristan Manalac
Bankruptcy
Biopharma Bankruptcies Still At Peak, With Little Relief in Sight
2023 marked the most bankruptcies in biopharma in more than a decade, with 14 companies filing for Chapter 11 protection. The number remained high in 2024.
February 19, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio
April 22, 2025
·
8 min read
Press Releases
Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th
March 25, 2025
·
2 min read
Press Releases
Holland Foundation for Sight Restoration Announces Second Annual Ocular Surface Stem Cell Transplantation Education Conference
September 4, 2024
·
1 min read
Business
Sight Sciences to Report Second Quarter Financial Results on August 1, 2024
July 18, 2024
·
2 min read
1 of 15,917
Next
